Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „Combination“
Suchtreffer
Begriffe & Kennungen
Calquence · 4.8 · Of the 297 patients treated with Calquence in combination with bendamustine and rituximab, discontinuation of
Eintrag öffnenCalquence · 4.8 · Of the 297 patients treated with Calquence in combination with bendamustine and rituximab, the most common (≥
Eintrag öffnenCalquence · 4.8 · Of the 297 patients treated with Calquence in combination with bendamustine and rituximab, the most common (≥
Eintrag öffnenCalquence · 4.8 · Serious infections when treating patients with Calquence in combination with venetoclax with or without obinut
Eintrag öffnenCalquence · 4.8 · Serious infections when treating patients with Calquence in combination with venetoclax with or without obinut
Eintrag öffnenCamzyos · 4.5 · Strong CYP2C19 plus strong CYP3A4 inhibitors Co-administration of mavacamten with the combination of a strong
Eintrag öffnenCapecitabine Accord · 4.5 · Folinic acid/folic acid A combination study with capecitabine and folinic acid indicated that folinic acid has
Eintrag öffnenCapecitabine Accord · 4.8 · 15 Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensor
Eintrag öffnenCapecitabine Accord · 4.8 · Capecitabine in combination therapy Table 6 lists ADRs associated with the use of capecitabine in combination
Eintrag öffnenCapecitabine Accord · 4.8 · Table 6 Summary of related ADRs reported in patients treated with capecitabine in combination treatment in add
Eintrag öffnenCapecitabine Medac · 4.5 · Folinic acid/folic acid A combination study with capecitabine and folinic acid indicated that folinic acid has
Eintrag öffnenCapecitabine Medac · 4.8 · Capecitabine in combination therapy Table 5 lists ADRs associated with the use of capecitabine in combination
Eintrag öffnenCapecitabine Medac · 4.8 · Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensory n
Eintrag öffnenCapecitabine Medac · 4.8 · Table 5 Summary of related ADRs reported in patients treated with capecitabine in combination treatment in add
Eintrag öffnenCapecitabine Teva · 4.5 · Folinic acid/folic acid A combination study with capecitabine and folinic acid indicated that folinic acid has
Eintrag öffnenCapecitabine Teva · 4.8 · Capecitabine in combination therapy Table 5 lists ADRs associated with the use of capecitabine in combination
Eintrag öffnenCapecitabine Teva · 4.8 · Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensory n
Eintrag öffnenCapecitabine Teva · 4.8 · Table 5 Summary of related ADRs reported in patients treated with capecitabine in combination treatment in add
Eintrag öffnenCarmustine medac (previously Carmustine Obvius) · 4.5 · Phenytoin and dexamethasone In combination with chemotherapeutic medicinal products reduced activity of antiep
Eintrag öffnenCellCept · 4.8 · 15 Hypogammaglobulinaemia has been reported in patients receiving mycophenolate mofetil in combination with ot
Eintrag öffnen